comparemela.com
Home
Live Updates
Control of external contaminants during CGT materials produc
Control of external contaminants during CGT materials produc
Control of external contaminants during CGT materials production
The quality of materials and reagents used in Cell and Gene Therapy (CGT) production processes plays avital role in determining both the product quality as well as therapeutic safety, and external contaminantsmust be strictly controlled.
Related Keywords
Aimee Molineux ,
Chapters ,
National Institute For Biological Standards ,
Drug Administration ,
European Medicines Agency ,
International Conference On Harmonization ,
Sponsored Content ,
Gene Therapy ,
Tissue Engineered Products ,
Biological Origin ,
Gene Therapy Medicinal Products ,
European Collection ,
Authenticated Cell Cultures ,
Cell Line Characterization ,
Cell Lines Used ,
Cell Substrates ,
Viral Vaccines ,
Infectious Disease ,
Safety Evaluation ,
Biotechnology Products Derived ,
Cell Lines ,
Virus Safety Evaluation ,
Biotechnological Investigational Medicinal ,
Medicines Agency ,
Host Cell Protein ,
National Institute ,
Biological Standards ,
Content Policy ,
News Medical Net ,
Cell And Gene Therapy ,
Xternal Contaminant ,